中國太平(00966.HK)料下半年投資收益增長趨勢可持續
中國太平(00966.HK)上半年純利按年增長78%,其中已實現投資收益按年增近一倍至134.11億元。公司投資管理部總經理吳松於業績會議上表示,上半年投資表現明顯高於同業水平,受惠於公司提早部署,及期內投資環境有利,上半年增長亦為公司提供空間,相信全年投資表現可達公司目標。
他指,雖然新型肺炎疫情仍然反覆,惟相信中國經濟仍將穩中向好,基本面有支持,下半年公司投資將錄得穩定收益,期間亦將有不少優質非標資產落地。
公司管理層並於業績會議上表示,上半年新業務價值增長,除了受惠於低基數,亦由於各渠道推動,其中銀保新業務價值增長由負轉正,料下半年可維持增長動力,高價值業務佔比亦有所提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.